SEVERITY OF THROMBOCYTOPENIA IN XXXX WITH @entity3965 MALARIA; A SINGLE CENTER STUDY.

@entity1 @entity882 @entity548 @entity3965 @entity311
BACKGROUND: @entity882 has been frequently observed in @entity3965 @entity311 in different studies. Finding out the severity of @entity882 --is perhaps equally important, as it has practical as well as prognostic implications. The objective of the study was to assess the severity of @entity882 in @entity1 suffering, from @entity311 caused by @entity3965 . METHODS: This cross-sectional study was carried out at Combined Military Hospital (CMH) Malir, Karachi, which is a tertiary care Hospital for all military personnel _ their families in the province of Sindh. All @entity1 of smear positive Vivax malariaduring the study period were, included, and those having @entity882 from any other reason were excluded. They were treated with antimalarial drugs and their platelet counts were monitored till they normalized and discharged from the hospital. Thrombobytopenia was defined as platelets count of <150,000/cu mm. Results were. analysed by SPSS 11. RESULTS: Out of 150 cases, 133 (88%) had @entity882 . Their ages ranged from 15 to 55; mean age was 35 with SD +/- 20. Low platelet count observed was between 11,000 and 146,000/cu mm with SD +/- 27404. Mean value was 79,832/cu mm. None of the @entity1 had any @entity548 episode requiring a blood transfusion. CONCLUSION: @entity3965 associated @entity882 has a benign outcome. irrespective of severity of the platelet counts.
